[Asia Economy Reporter Hyungsoo Park] MikobioMed, a manufacturer of in vitro diagnostic medical devices, announced on the 24th that internal research confirmed that its COVID-19 antigen test kit accurately detects both Stealth Omicron and Deltacron variants.


Recently, the Stealth Omicron (BA.2) variant's prevalence has reached 60% worldwide and nearly 40% domestically, while in Thailand, the ‘Deltacron’ variant, a mix of Delta and Omicron, has also been identified.


MikobioMed proactively confirmed that its antigen test kit can diagnose infections of both Stealth Omicron and Deltacron variants.


A company official stated, "Internal research using various variant samples confirmed that our kit can detect not only major variants of concern such as Alpha, Beta, and Delta but also the rapidly increasing Stealth Omicron and the highly fatal Deltacron."


The official added, "In addition to existing major variants, we have also developed our PCR kit capable of detecting Omicron and Stealth Omicron variants," expressing confidence in responding to various mutations. MikobioMed's Stealth Omicron PCR diagnostic kit has already been exported to countries including Brazil since the end of last year.



Kim Sung-woo, CEO of MikobioMed, emphasized, "Even if new variant viruses emerge, we will make every effort to enable the rapid development and supply of various molecular and immunodiagnostic kits."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing